Clinical course of breast cancer patients with liver metastases.
Authors:
- J W ZinserJZJ W Zinser
- G N HortobagyiGHG N Hortobagyi
- A U BuzdarABA U Buzdar
- T L SmithTST L Smith
- G FraschiniGFG Fraschini
- 1 May 1987
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 5 (5) , 773-782
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Comparison of consecutive series of patients in 1950s, 1960s, and 1970sCancer, 1985
- Estrogen receptors and the pattern of relapse in breast cancerArchives of internal medicine (1960), 1984
- Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectumDiseases of the Colon & Rectum, 1982
- Oestrogen-receptor status and sites of metastasis in breast cancerBritish Journal of Cancer, 1981
- Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapyCancer, 1980
- Causes of death in breast cancer a clinicopathologic studyCancer, 1980
- Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug TherapyAnnals of Internal Medicine, 1979
- PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER TREATED WITH COMBINATION CHEMOTHERAPY1979
- A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer.A southeastern cancer study group projectCancer, 1977
- Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustardCancer, 1976